Earn Dividends in Emerging Markets with This WisdomTree ETF
This exchange-traded fund boasts a spiffy yield and should protect you in down markets.
You usually don’t find the words “emerging markets” and “dividends” in the same sentence. You buy emerging markets stocks for growth, with dividends pretty much an afterthought.
Meet WisdomTree Emerging Markets Equity Income ETF (symbol (DEM). This exchange-traded fund focuses on emerging-markets stocks that share the wealth.
WisdomTree ETFs differ from typical index funds. Conventional index funds use market value (share price times number of shares outstanding) to decide how much of each stock to buy. In contrast, WisdomTree weights companies based on the amount of dividends they pay out (dividends per share times number of shares outstanding).
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
So Taiwan Semiconductor, which has 25.9 billion shares outstanding and pays out 10 cents per share per year, is WisdomTree’s top holding. The company paid out $2.7 billion in dividends over the past 12 months, earning it a 3.5% weighting in the ETF.
The fund is that simple. But its performance has been superb. From its inception in July 2007 through May 7, the ETF returned an annualized 5.6%. That’s an average of 5.9 percentage points per year better than the MSCI Emerging Markets index. The ETF currently yields 6.2%.
Will such incredible performance continue? In bad markets -- with the notable exception of the 2007-09 bear market -- investors have flocked to stocks that pay healthy dividends. And emerging markets -- by definition more volatile than developed markets -- have suffered plenty of bad markets of late.
Consider the numbers. During the 2007-09 disaster, Standard & Poor’s 500-stock index plunged 55.3%. But the MSCI Emerging Markets index was torpedoed for a 60.2% loss. On a relative basis, the WisdomTree ETF did much better, losing 47.0%.
What’s more, emerging markets suffered a second bear market last year. From May 2 through November 25, the MSCI index lost 25.9%, but the WisdomTree ETF lost only 22.5%. The ETF’s outperformance on the down side shouldn’t be surprising; it has been about 15% less volatile than the MSCI index.
But dividends don’t always pay off. Jeremy Schwartz, research director at WisdomTree, says dividend-paying stocks thrive when value stocks outperform -- which hasn’t been the case in the U.S. since WisdomTree opened its doors. Since the launch of WisdomTree U.S. Equity Income ETF (DHS), the firm’s oldest fund, in 2006, the ETF has outperformed the Vanguard Value Index (VIVAX), an index mutual fund that invests in large, undervalued companies, by a mere 0.2 percentage point per year. The Vanguard index, in turn, has trailed the S&P 500 by an average of 1.8 points per year.
Many of WisdomTree’s other domestic funds have lagged their benchmarks for the same reason, Schwartz says, primarily because their dividend strategy led them to hold a lot of financial stocks, which blew up during the 2007-09 bear market.
WisdomTree’s foreign funds, in general, have done better than its domestic funds, and most have beaten their benchmarks. Schwartz says more companies outside the U.S. pay generous dividends. Consequently, the foreign ETFs held less in financial stocks.
WisdomTree’s emerging markets fund has been the standout. It’s the biggest of the company’s 48 ETFs, with $3.8 billion in assets. More than 90% of emerging markets stocks pay dividends; that compares with about 75% of U.S. companies.
I think part of the fund’s success stems from the nature of dividends -- and part has to do with luck. I’ve been unable to identify a single good actively managed, no-load emerging markets stock fund. Managers in this category are bedeviled by lack of transparency in corporate reporting, high trading costs and corruption. My hunch is that when you put in a big buy order with a local brokerage in an emerging market, the broker, his or her family, and a dozen of their best friends often buy the stock before your order gets filled. With an index fund, even an arcane index fund such as WisdomTree’s, you don’t have that problem because index funds trade infrequently.
More important, dividends -- unlike quarterly earnings reports -- don’t lie. When corporate managers in emerging markets pay dividends, they may also be saying something about their own ethics. Or, it could be that their families own a ton of the stock. Either way, the executives are on the same side as the shareholders.
Look closely at the holdings of the WisdomTree ETF and you’ll find significant contrasts with the MSCI index. The ETF has 21% of its assets in Brazil (compared with 13% in the index), 22% in Taiwan (compared with 11%), 10% in South Africa (8%) and 9% in Malaysia (4%). On the other side of the coin, it has just 3% in China (19% in the MSCI index), 2% in Russia (7%) and nothing in India (6%).
Some of these big bets strike me as sensible. I wouldn’t invest a ruble in a Russian stock. To some extent, the ETF’s dividend strategies may push it toward more-honest markets.
But good fortune is also at work here. The bottom line: Don’t buy this fund because you think it’ll keep beating the index by a ton. Buy it because you think it will do a bit better than the index and protect you more than a little in down markets.
Steven T. Goldberg is an investment adviser in the Washington, D.C. area.
ORDER NOW: Buy Kiplinger’s Mutual Funds 2012 special issue for in-depth guidance on the only investments you need.
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
-
Stock Market Today: Stocks End Higher in Whipsaw Session
The main indexes were volatile Thursday with Nvidia earnings in focus.
By Karee Venema Published
-
Trump Picks Dr. Oz as Head of Medicare and Medicaid
President-elect Donald Trump picked Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid Services. Here's what to know about the former TV host.
By Kathryn Pomroy Published
-
ESG Gives Russia the Cold Shoulder, Too
ESG MSCI jumped on the Russia dogpile this week, reducing the country's ESG government rating to the lowest possible level.
By Ellen Kennedy Published
-
Morningstar Fund Ratings Adopt a Stricter Curve
investing Morningstar is in the middle of revamping its fund analysts' methodology. Can they beat the indices?
By Steven Goldberg Published
-
Market Timing: The Importance of Doing Nothing
Investor Psychology Investors, as a whole, actually earn less than the funds that they invest in. Here’s how to avoid that fate.
By Steven Goldberg Published
-
Commission-Free Trades: A Bad Deal for Investors
investing Four of the biggest online brokers just cut their commissions to $0 per transaction. Be careful, or you could be a big loser.
By Steven Goldberg Published
-
Vanguard Dividend Growth Reopens. Enter at Will.
investing Why you should consider investing in this terrific fund now.
By Steven Goldberg Published
-
Health Care Stocks: Buy Them While They're Down
investing Why this sector should outperform for years to come
By Steven Goldberg Published
-
Buy Marijuana Stocks Now? You'd Have to Be Stoned.
stocks Don't let your investment dollars go to pot
By Steven Goldberg Published
-
4 Valuable Lessons From the 10-Year Bull Market
Investor Psychology Anything can happen next, so you must be mentally prepared.
By Steven Goldberg Published